| Mifeprex (mifepristone) / Danco Laboratories |
NCT00043654: Clinical Trial of Mifepristone for Bipolar Depression |
|
|
| Completed | 2 | 110 | US | Mifepristone | National Institute of Mental Health (NIMH) | Bipolar Disorder | | 06/07 | | |
| Withdrawn | 2 | 0 | Canada | mifepristone (RU-486), Mifepristone, Placebo | University of British Columbia, Western Economic Diversification Canada, Stanley Medical Research Institute | Bipolar Depression | 12/10 | 12/10 | | |
NCT00833339: Trial of Mifepristone in Combat Veterans With Posttraumatic Stress Disorder |
|
|
| Unknown status | 2 | 80 | US | mifepristone, placebo | James J. Peters Veterans Affairs Medical Center | Posttraumatic Stress Disorder | 10/15 | 10/15 | | |
NCT01212588: Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) |
|
|
| Terminated | 2 | 22 | US | mifepristone, Placebo | Indiana University | Borderline Personality Disorder | 09/16 | 09/16 | | |
RESET-m, NCT05217758: edication Glucocorticoid Receptor (GR) Blockade as Disease Modifying Treatment for Depression With Childhood Trauma |
|
|
| Recruiting | 2 | 158 | Europe | Mifepristone, Placebo | VU University Medical Center, Netherlands Brain Foundation, Corcept Therapeutics | Major Depressive Disorder, Childhood Trauma | 12/23 | 06/24 | | |
NCT01333098: Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders |
|
|
| Completed | 1/2 | 15 | US | Mifepristone, Mifeprex, RU-486 | Washington University School of Medicine | Anxiety Disorders | 04/13 | 04/13 | | |
